X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-18 | DAWN | Bender Jeremy | CEO | S - Sale+OE | $13.21 | -10,554 | 1,717,215 | -1% | -$139,420 | |||||
| D | 2024-11-18 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale+OE | $13.21 | -2,206 | 2,064,015 | 0% | -$29,142 | |||||
| D | 2024-11-18 | DAWN | Dubow Adam | GC | S - Sale+OE | $13.21 | -3,165 | 32,162 | -9% | -$41,810 | |||||
| D | 2024-11-18 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale+OE | $13.21 | -2,602 | 240,133 | -1% | -$34,373 | |||||
| M | 2024-11-08 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.15 | -28,255 | 2,057,535 | -1% | -$456,223 | |||||
2024-11-07 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.03 | -11,245 | 2,085,790 | -1% | -$180,287 | ||||||
2024-10-31 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.02 | -500 | 2,097,035 | 0% | -$8,010 | ||||||
2024-09-10 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $14.22 | -30,000 | 2,097,535 | -1% | -$426,675 | ||||||
| D | 2024-08-16 | DAWN | Dubow Adam | GC | S - Sale+OE | $14.00 | -3,202 | 26,928 | -11% | -$44,825 | |||||
| D | 2024-08-16 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale+OE | $14.00 | -2,633 | 232,485 | -1% | -$36,860 | |||||
| D | 2024-08-16 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale+OE | $14.00 | -2,232 | 2,127,535 | 0% | -$31,246 | |||||
| D | 2024-08-16 | DAWN | Bender Jeremy | CEO | S - Sale+OE | $14.00 | -10,681 | 1,707,770 | -1% | -$149,524 | |||||
2024-07-16 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.01 | -20,000 | 2,121,081 | -1% | -$320,226 | ||||||
2024-06-21 | DAWN | Ramasastry Saira | Dir | S - Sale | $13.19 | -10,000 | 40,485 | -20% | -$131,877 | ||||||
2024-06-10 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $12.62 | -30,000 | 2,141,081 | -1% | -$378,588 | ||||||
| D | 2024-05-16 | DAWN | Bender Jeremy | CEO | S - Sale+OE | $16.08 | -7,873 | 1,698,452 | 0% | -$126,588 | |||||
| D | 2024-05-16 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale+OE | $16.08 | -2,267 | 2,171,081 | 0% | -$36,450 | |||||
| D | 2024-05-16 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale+OE | $16.08 | -2,675 | 224,868 | -1% | -$43,011 | |||||
| D | 2024-05-16 | DAWN | Dubow Adam | GC | S - Sale+OE | $16.08 | -3,253 | 21,731 | -13% | -$52,304 | |||||
2024-05-10 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.37 | -10,000 | 2,164,662 | 0% | -$163,743 | ||||||
| M | 2024-05-01 | DAWN | Bender Jeremy | CEO | S - Sale | $17.87 | -79,211 | 1,686,326 | -4% | -$1,415,707 | |||||
| M | 2024-05-01 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale | $17.88 | -60,461 | 217,293 | -22% | -$1,081,191 | |||||
2024-04-18 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.02 | -10,000 | 2,174,662 | 0% | -$160,163 | ||||||
2024-03-25 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.01 | -10,000 | 2,184,662 | 0% | -$160,055 | ||||||
2024-03-11 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $15.24 | -30,000 | 2,194,662 | -1% | -$457,314 | ||||||
2024-02-27 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.11 | -20,000 | 2,224,662 | -1% | -$322,166 | ||||||
| D | 2024-02-16 | DAWN | Dubow Adam | GC | S - Sale+OE | $15.25 | -3,242 | 16,585 | -16% | -$49,434 | |||||
| D | 2024-02-16 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale+OE | $15.25 | -2,666 | 277,754 | -1% | -$40,651 | |||||
| D | 2024-02-16 | DAWN | Blackman Samuel C. | Head of Research, Developme | S - Sale+OE | $15.25 | -2,258 | 2,244,662 | 0% | -$34,430 | |||||
| D | 2024-02-16 | DAWN | Bender Jeremy | CEO | S - Sale+OE | $15.25 | -7,615 | 1,765,537 | 0% | -$116,114 | |||||
| D | 2023-11-16 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale+OE | $11.69 | -956 | 270,170 | 0% | -$11,176 | |||||
| D | 2023-11-16 | DAWN | Dubow Adam | GC | S - Sale+OE | $11.69 | -5,313 | 11,428 | -32% | -$62,109 | |||||
| D | 2023-11-16 | DAWN | Blackman Samuel C. | Head of Research, Developme | S - Sale+OE | $11.69 | -709 | 2,238,234 | 0% | -$8,288 | |||||
| D | 2023-11-16 | DAWN | Bender Jeremy | CEO | S - Sale+OE | $11.69 | -3,107 | 1,753,153 | 0% | -$36,321 | |||||
| M | 2023-10-18 | DAWN | Ai Day1 LLC | 10% | P - Purchase | $10.15 | +1,475,454 | 12,929,322 | +13% | +$14,978,327 | |||||
| D | 2023-08-17 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale+OE | $13.86 | -922 | 267,501 | 0% | -$12,779 | |||||
| D | 2023-08-17 | DAWN | Blackman Samuel C. | Head of Research, Developme | S - Sale+OE | $13.86 | -668 | 2,236,319 | 0% | -$9,258 | |||||
| D | 2023-08-17 | DAWN | Bender Jeremy | CEO | S - Sale+OE | $13.86 | -2,996 | 1,747,948 | 0% | -$41,525 | |||||
2023-06-09 | DAWN | Ai Day1 LLC | 10% | P - Purchase | $13.00 | +769,230 | 11,453,868 | +7% | +$9,999,990 | ||||||
2023-06-05 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $16.00 | -1,229 | 2,234,363 | 0% | -$19,664 | ||||||
| D | 2023-05-16 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale+OE | $13.12 | -955 | 264,798 | 0% | -$12,532 | |||||
| D | 2023-05-16 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale+OE | $13.12 | -692 | 2,235,592 | 0% | -$9,081 | |||||
| D | 2023-05-16 | DAWN | Bender Jeremy | CEO | S - Sale+OE | $13.12 | -3,104 | 1,742,632 | 0% | -$40,732 | |||||
2023-03-10 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $18.05 | -10,000 | 2,233,660 | 0% | -$180,484 | ||||||
2023-03-07 | DAWN | Bender Jeremy | CEO | S - Sale | $20.01 | -12,500 | 1,737,424 | -1% | -$250,114 | ||||||
2023-03-01 | DAWN | Grant Julie Papanek | Dir | S - Sale | $18.61 | -25,000 | 2,880,761 | -1% | -$465,303 | ||||||
2023-02-17 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale | $20.03 | -9,377 | 262,128 | -3% | -$187,790 | ||||||
| D | 2023-02-16 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale+OE | $19.57 | -930 | 271,505 | 0% | -$18,203 | |||||
| D | 2023-02-16 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale+OE | $19.57 | -674 | 2,243,660 | 0% | -$13,192 | |||||
| D | 2023-02-16 | DAWN | Bender Jeremy | CEO | S - Sale+OE | $19.57 | -3,022 | 1,749,924 | 0% | -$59,150 | |||||
2023-02-10 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $20.07 | -10,000 | 2,241,710 | 0% | -$200,659 | ||||||
2023-02-01 | DAWN | Grant Julie Papanek | Dir | S - Sale | $21.23 | -25,000 | 2,905,761 | -1% | -$530,794 | ||||||
2023-01-23 | DAWN | Bender Jeremy | CEO | S - Sale | $22.00 | -12,500 | 1,744,634 | -1% | -$274,988 | ||||||
2023-01-20 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale | $22.75 | -10,000 | 268,810 | -4% | -$227,523 | ||||||
2023-01-10 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $22.86 | -10,000 | 2,250,148 | 0% | -$228,644 | ||||||
2023-01-03 | DAWN | Grant Julie Papanek | Dir | S - Sale | $20.65 | -25,000 | 2,930,761 | -1% | -$516,147 | ||||||
2022-12-21 | DAWN | Bender Jeremy | CEO | S - Sale | $20.32 | -12,500 | 1,755,572 | -1% | -$253,969 | ||||||
2022-12-20 | DAWN | York Charles N II | COO, CFO, Secretary | S - Sale | $20.07 | -10,000 | 276,497 | -3% | -$200,650 | ||||||
2022-12-08 | DAWN | Grant Julie Papanek | Dir | S - Sale | $22.08 | -4,358 | 2,955,761 | 0% | -$96,210 | ||||||
| M | 2022-12-01 | DAWN | Grant Julie Papanek | Dir | S - Sale | $21.65 | -10,000 | 2,960,119 | 0% | -$216,480 | |||||
2022-12-01 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $21.45 | -10,000 | 2,260,148 | 0% | -$214,530 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |